Attend
Read
Watch
Listen
About Us
Stay Informed.
Sign-up for the SynBioBeta Weekly Digest and stay on top of all the industry news.
Thank you!
We'd love to ask a few more questions to better customize your experience.
Oops! Something went wrong while submitting the form.
Thank You!
We'd love to get to know you just a bit more.
Take a few minutes to personalize your content.
What is the size of your company?
Synbio Stack?
Synbio Stack?
BACK
NEXT
Thank you!
You are now subscribed.
Oops! Something went wrong while submitting the form.
Weekly Digest
Metabolic Engineering of Plant Secondary Metabolism in Non-conventional Yeast
-
Synbio -Technologies
A non-conventional yeast strain was developed to produce flavor and fragrance compound through synthetic biology, metabolic analysis, and fermentation optimization.
Applying a Workstation Approach to Automating The Synthetic Biology Workflow
-
Hudson Robotics
There is a myriad of ways to approach automation and particularly synthetic biology, and many have merit. What is presented here is a modular approach that can support considerable productivity quickly, yet grow into a fully integrated system if that is desired and is warranted. Workcells that automate the synthetic biology building blocks of transformation, growth and selection, extraction and purification, quantitation are often separate workflows that allow a break point of islands or silos of automation. However, workcells that are islands or silos can themselves cause productivity issues and full automation is often the end goal.
Moving Synthetic Biology Forward with Interdisciplinary Training
-
Catalog DNA
As enterprises increasingly embrace biology-driven solutions to traditionally nonbiological problems, development teams are faced with novel and highly complex technical challenges. Breaking new ground in these areas requires a level of consilience, for scientists have the necessary interdisciplinary training to draw from deep expertise in chemistry, computer science, engineering, and more. Synbio is at the precipice of unprecedented breakthroughs in countless sectors of industry and companies are hungry for talented scientists that will drive cross-cutting teams.
Next Steps in Next Generation Pet Food
-
Wild Earth
Discussion will focus on Wild Earth's immediate goals to advance the future of pet food in the plant-based and cell-based food space, including a brief look at our longevity research.
Synthetic Biology and the Energy Transition Opportunity
-
Cemvita Factory
Energy Transition is already happening and has led to heavy industries (Chemicals, Oil & Gas, Mining, etc.) accelerating their decarbonization efforts to maintain the support of ESG investors. The great challenge is how to how to balance sustainability and profitability. Synthetic Biology is a viable solution for creating a double bottom line.
Why the world needs an intranasal COVID-19 vaccine
-
Meissa Vaccines
The vaccine race against COVID-19 is both a sprint and a marathon. Injected vaccines successfully completed the sprint and are preventing severe disease, but they cannot block transmission. This talk will discuss why the next vaccine for COVID-19 must be intranasal and why it also should be live attenuated and recombinant.
Bioluminescent Plants are Here!
-
Light Bio
People love glowing plants, but this has been mere fantasy until now. Light Bio has the only technology to make glowing plants a reality. Ornamental plants that emit living light are now being developed for use in homes and gardens. With their soft illumination, these plants bring forth a magical experience. And they are here at SynBioBeta to provide the world’s first exhibit of live glowing plants.
Networking Microbiome Science for the Generative Economy
-
Eagle Genomics
Understanding and harnessing the power of microbiomes—both individual and ecological—holds the key to tackling many of the worlds’ Grand Challenges. But effectively implementing these solutions requires a robust data fabric and the application of network science. By providing a microbiome innovation ecosystem, Eagle Genomics is enabling companies to drive sustainable innovation across food, personal care, agritech, and healthcare.
Imagine switching off the world's cement kilns, through decarbonizing the cement industry with biology
-
bioMason
Climate change is the biggest challenge to solve this decade. Concrete is the second most consumed substance on the planet following water. The production of Portland cement, the active ingredient in concrete- is responsible for 8% of global CO2 emissions due to the firing of limestone to get calcium. Using blueprints from nature, Biomason creates cement in a radically different way eliminating the need to emit carbon during production—curing the root disease, rather than treating the symptoms. Biomason is the only company in the world employing biology to produce cement, and our goal is to eliminate 25% of the concrete industry’s global carbon emissions by 2030.
Enzymes as Molecular Dissasemblers
-
Aether
Building a future of abundance will require a paradigm shift in how we assemble molecular products from basic building blocks as well as how we disassemble toxic pollutants in our environment. Aether is building an intelligent enzyme engineering platform to tackle these challenges by generating datasets of unprecedented size, and designing novel enzymes to catalyze reactions that are impossible today. This will enable the next generation of molecular products, and to detoxification our environment.